Search CatalystAlert
Search for companies, drugs, and catalysts
Search CatalystAlert
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Drugs in Pipeline
11
Phase 3 Programs
9
Upcoming Catalysts
1
Next Catalyst
Dec 15, 2026
51w| Drug Name | Phase |
|---|---|
AXS-07 (meloxicam-rizatriptan) | Phase 3 |
AXS-12 (reboxetine) | Phase 3 |
Solriamfetol 150 mg | Phase 3 |
Placebo | Phase 3 |
AXS-07 (MoSEIC meloxicam and rizatriptan) | Phase 3 |
AXS-05 | Phase 3 |
AXS-05 (dextromethorphan and bupropion) oral tablets | Phase 3 |
Solriamfetol 300 mg | Phase 3 |
AXS-07 | Phase 3 |
Bupropion | Phase 2 |
AXS-05 (dextromethorphan-bupropion) | Phase 2 |
1 upcoming, 2 past
Primary completion for Solriamfetol 150 mg trial (NCT06568367) in Excessive Sleepiness
Source